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The effects of axillary block using the multiple injection method
with ropivacaine in uremic and nonuremic patients*
Hüyla ÇEVİK, Ahmet MAHLİ, Demet COŞKUN

Aim: To compare the sensory and motor block quality in axillary brachial plexus block using the multiple injection
method with ropivacaine in uremic and nonuremic patients.
Materials and methods: Examined were 60 patients scheduled for orthopedic surgery of the distal upper extremity
(nonuremic group: group N, n = 30) or creation of an arteriovenous fistula (uremic group: group U, n = 30) with an
axillary brachial plexus block. The median, radial, ulnar, and musculocutaneous nerves were selectively localized by
nerve stimulation. After obtaining an appropriate peripheral motor response, predetermined volumes of ropivacaine
(0.5%), in accordance with a formula, were selectively injected to the 4 nerves by multiple injections in both groups.
Sensory and motor block were assessed.
Results: At 30 min, complete sensory and motor block was observed at a rate of 95% in the ulnar nerve innervation area
and 100% in the other 3 nerves in group U, whereas these rates were 95% in the musculocutaneous nerve innervation
area and 100% in the other 3 nerves in group N. There was no statistically significant difference between the groups.
Conclusion: Axillary brachial plexus block using the multiple injection method with ropivacaine in uremic and
nonuremic patients provided a similarly good quality of the block and lack of systemic toxicity.
Key words: Axillary block, multiple injections, ropivacaine, uremic patient

Üremik olan ve olmayan hastalarda ropivakain ile çoklu enjeksiyon yöntemi
kullanılarak yapılan aksiller bloğun yayılımı
Amaç: Çalışmamızda, üremik olan ve olmayan hastalarda, ropivakain ile çoklu enjeksiyon yöntemi kullanılarak yapılan
aksiller blokta oluşan duyusal ve motor bloğun kalitesini karşılaştırdık.
Yöntem ve gereç: Ortopedik distal üst ekstremite cerrahisi (üremik olmayan grup; grup ÜO, n = 30) ya da arteriovenöz
fistül açılması (üremik grup; grup Ü, n = 30) planlanmış 60 hastada aksiler brachial plexus bloğu uygulanarak çalışma
yapıldı. Median, radial, ulnar, ve muskulokutanöz sinirler sinir stimülatörü ile selektif olarak stimüle edildi. Her iki
grupta da benzer şekilde, uygun periferik motor yanıt alındıktan sonra çoklu enjeksiyon yöntemi ile dört sinire selektif
olarak, formüle göre önceden belirlenmiş volümde ropivakain (% 0,5) enjeksiyonu yapıldı. Duyusal ve motor blok
değerlendirildi.
Bulgular: Otuzuncu dakikadaki tam duyusal ve motor blok, grup Ü’de, ulnar sinir innervasyon alanında % 95, diğer
üç sinirde % 100; grup ÜO’da ise muskulokutanöz sinir innervasyon alanında % 95, diğer üç sinirde % 100 oranlarında
gözlenmiştir. Gruplar arasında istatistiksel olarak belirgin bir fark yoktur.
Sonuç: Ropivakain ile çoklu enjeksiyon yöntemi kullanılarak yapılan aksiller blokta, üremik olan ve olmayan hastalarda
benzer şekilde iyi kalitede ve sistemik toksisite olmaksızın blok sağlanmaktadır.
Anahtar sözcükler: Aksiller blok, çoklu enjeksiyon, ropivakain, üremik hasta
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Introduction
A common regional anesthetic technique used for
surgical anesthesia of the arm and hand is the axillary
approach to neural block of the upper extremity. An
axillary block is frequently used, not only in a variety
of orthopedic and soft tissue surgical procedures of
the upper extremity, but also in patients with endstage renal disease who have to undergo arteriovenous
fistula creation or revision for hemodialysis access (1).
These patients are governed by the presence of risk
factors such as hypertension, anemia, coagulopathy,
metabolic acidosis, and/or hyperkalemia, which are
directly associated with uremia, and many others
such as ischaemic heart disease, diabetes, mellitus
and chronic pulmonary disease (2). When a brachial
plexus block is performed for procedures related
to vascular access for hemodialysis, the resulting
analgesia and sympathetic blockade provide optimal
surgical conditions and, subsequently, adequate
duration of the postoperative block prevents arterial
spasm and graft thrombosis (3).
Since toxicity of local anesthetics with an axillary
block is increased in uremic patients, selection of the
local anesthetic and block procedure are important.
The increased toxicity and shorter duration of axillary
block in uremic patients is known (1,4-6), the lower
toxicity of ropivacaine is known, and axillary block
with ropivacaine in uremic patients has already been
reported (7). In contrast to those reports, in order to
identify the merit of the multiple injection method
of axillary block, we compared the quality of sensory
and motor block with ropivacaine between uremic
patients and nonuremic patients.
Materials and methods
This study was approved by the local ethics committee,
and informed consent was obtained from all of the
patients. The patient population included patients of
American Society of Anesthesiologists physical status
I-III, aged 18-65 years, and scheduled for orthopedic
surgery of the distal upper extremity (nonuremic
group: group N, n = 30) or creation or revision of an
arteriovenous fistula (uremic group: group U, n = 30)
with an axillary brachial plexus block. Patients with a
history of neurological, neuromuscular, or psychiatric
disorders or hepatic, respiratory, or cardiac diseases
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were excluded. Patients with a history of drug or
alcohol abuse, coagulation disorders, or uncontrolled
seizures were also excluded, as were pregnant or
lactating women.
No drugs as premedication were given to the
patients, whose routine laboratory examinations
were conducted preoperatively, prior to the surgery,
since full cooperation during block assessment was
required. All of the uremic patients included in the
study were chronic hemodialysis patients and they
had received hemodialysis treatment 1 day before the
block performance. Prior to the procedure, all of the
patients had a normal prothrombin time and partial
thromboplastin time. After arrival in the anesthetic
room, an 18- or 20-gauge intravenous catheter
was placed in the upper limb, contralateral to the
surgical site. A venous blood gas sample was taken
in a 2-mL injector containing heparin and assessed
in a blood gas device (Nova Biomedical, USA).
From this vascular access, normal saline was given
at an hourly rate of 2 mL/kg. Monitoring included
electrocardiography (ECG), noninvasive blood
pressure, and pulse oximetry. Supplemental oxygen
(nasal cannula at 4 L/min) was applied throughout
the procedure. A perivascular axillary brachial plexus
block was performed. The plexus was identified with a
short-beveled electric stimulation needle (Stimuplex,
B. Braun Melsungen AG, Germany) connected to
a nerve stimulator using a low current (<1.0 mA).
The volume of local anesthetic for each patient was
calculated according to a formula that takes height as
a criterion [(volume (mL) = height (cm) / 5)] (8). The
median, radial, ulnar, and musculocutaneous nerves
were selectively localized by elicited characteristic
muscle group movements, secondary to each
nerve stimulation. After obtaining an appropriate
peripheral motor response with a current near or
below 0.5 mA with respect to the stimulation of
each nerve, predetermined volumes (30-35 mL)
of ropivacaine, in accordance with the formula at a
concentration of 0.5% (Naropin, 5 mg/mL ampoule,
Astra Zeneca, Sweden), were selectively injected
into each nerve; that is, the predetermined volume
was divided into equal amounts, through multiple
injection in both groups, with intermittent aspiration.
Verbal contact with the patients was maintained
throughout the injection, and before the injections
were made, the patients were informed about the
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signs of local anesthetic toxicity, such as numbness of
the lips and tongue and lightheadedness. Firm digital
pressure was maintained during the injection and 3
min thereafter, immediately distal to the injection
site, to prevent distal flow of the ropivacaine solution.
The arm was then brought to rest at the patient’s side.
The hemodynamic parameters of heart rate, mean
arterial pressure, and oxyhemoglobin saturation
were monitored and recorded every 15 min during
the procedure.
The time of injection was considered the
beginning of all of the time intervals (time zero).
Sensory and motor block were assessed in each of
the 4 major peripheral nerve distributions at 3, 6, 9,
12, 15, 18, and 30 min and, thereafter, every 15 min
during the procedure and until recovery. Sensory
block was assessed by pinprick using the blunt end of
a 27-gauge dental needle and was graded according
to the following 3-point scale: 0 = no block (normal
sensation), 1 = partial block (decreased sensation),
and 2 = complete block (no sensation). Motor block
was measured by assessing the following motor
functions: flexion at the elbow (musculocutaneous
nerve), extension of the elbow and the wrist (radial
nerve), opposition of the thumb and index finger
(median nerve), and opposition of the thumb and
small finger (ulnar nerve). Motor block was graded
according to the following scale: 0 = no block (full
muscle activity), 1 = partial block (decreased muscle
activity), and 2 = complete block (no muscle activity).
The overall maximal composite score was 16 points.
We considered the patient ready for surgery when a
minimal composite score of 14 points was achieved,
provided that the sensory block score was equal to
or greater than 7 of 8 points (9). The onset time was
defined as the amount of time required to obtain
14 points. After 30 min, the patient was transferred
to the operating room for the start of the surgery.
Independently of the composite score, we deemed
a block successful if it provided surgical anesthesia.
The occurrence of pain during surgery rendered the
block a failure, and the patients were allowed local
anesthetic infiltration by the surgeon. Requirements
for additional local anesthetic infiltration and the
incidence of complications were noted. Duration of
sensory block (defined as a return of sensation to
pinprick in all of the nerve distributions) and duration
of motor block (time from onset to a motor block

score of 0 for all of the activities) were also measured.
After the operation, patients were monitored in the
postanesthesia care unit and were discharged from
the hospital after recovery from sensory and motor
blockade.
The results are expressed as mean values with
standard deviations. An unpaired Student’s t-test
or a Mann-Whitney U was used to compare the
demographic variables and operative data. For the
analysis of the quality of the block, a chi-square or
Fisher’s exact test was used. Differences were regarded
as statistically significant if P < 0.05.
Results
Demographic data were not significantly different
between the 2 groups, except for sex (P < 0.01). No
differences were observed in terms of the durations
of operation (Table 1).
The preoperative venous blood gas and electrolyte
values of the patients are presented in Table 2; it was
observed that the hemoglobin and Ca values of the
uremic group were significantly (P < 0.01) lower
than the values of the nonuremic group, whereas the
blood urea nitrogen (BUN) and creatinine values of
the same group were significantly higher (P < 0.01).
Again in the uremic group, the pH and HCO3- values
were significantly lower (P < 0.01), whereas the base
excess values were significantly higher (P < 0.01).
No statistically significant differences were found
between the 2 groups in terms of the other laboratory
values.
At 30 min following the block (Figures 1 and 2),
the score of 14 points required to start the operation
in the musculocutaneous, radial, median, and
ulnar nerves was reached in 100% of the patients
in both the nonuremic and uremic groups. There
were no differences in surgical anesthesia and in
the proportion of the blocks achieving a minimal
composite score of 14 points at 30 min. Motor and
sensorial block developed in the radial and median
nerves in 100% of the patients in both groups.
Complete sensory and motor block developed in
the musculocutaneous nerve in 95% of the patients
in group N and in 100% of the patients in group
U, and in the ulnar nerve in 100% of the patients
in group N and in 95% of the patients in group U.
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Table 1. Patient characteristics and duration of operation and sensory and motor block
(mean ± SD).
Nonuremic
(n = 30)

Uremic
(n = 30)

P-value

Sex (M/F)

8/22

18/12

<0.01

Age (years)

45 ± 10

49 ± 16

NS

Weight (kg)

73 ± 8

66 ± 12

NS

Height (cm)

166 ± 8

165 ± 12

NS

Duration of operation (min)

59 ± 21

61 ± 24

NS

Duration of sensory block (min)

571 ± 57

561 ± 51

NS

Duration of motor block (min)

704 ± 45

682 ± 53

NS

Groups

Table 2. Preoperative venous blood gas and electrolyte values (mean ± SD).
Nonuremic
(n = 30)

Uremic
(n = 30)

P-value

BUN (mg/dL)

18.9 ± 9.0

63.1 ± 18.1

<0.001

Creatinine (mg/dL)

0.82 ± 0.2

5.05 ± 1.9

<0.001

Hemoglobin (g/dL)

13.32 ± 2.0

11.21 ± 1.5

<0.001

K+ (mEq/L)

4.21 ± 0.4

4.40 ± 0.6

NS

Albumin (g/dL)

4.09 ± 0.5

3.62 ± 0.6

NS

Ca (mg/dL)

9.2 ± 0.5

8.2 ± 0.7

<0.001

pH

7.42 ± 0.13

7.36 ± 0.05

<0.001

pCO2 (mmHg)

40.1 ± 4.4

37.2 ± 5.8

NS

pO2 (mmHg)

46.0 ± 13.1

47.0 ± 9.9

NS

Base excess

–1.8 ± 2.3

–4.1 ± 4.6

<0.001

HCO3- (mEq/L)

26.2 ± 1.6

21.6 ± 3.3

<0.001

Venous blood gas and electrolytes

Partial motor and sensory block was observed in the
musculocutaneous nerve in 1 patient (5%) in group
N, and in the ulnar nerve in again 1 patient (5%) in
group U. When the sensory and motor development
speed was considered following the axillary block,
no statistically significant differences were observed
between the 2 groups. However, the sensory block
speed in the radial nerve at 9 min in group N was
significantly higher (P < 0.05) than in group U.
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Durations of the sensory as well as the motor block
(Table 1) were not significantly different between the
groups. No additional local anesthetic infiltration
was administered to any of the patients prior to or
during the operation.
No statistically significant differences were found
between the 2 groups in terms of the mean arterial
pressure values at all of the measurement times, and
they were within the normal limits. Additionally,
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Figure 1. Percentage of patients with sensory anesthesia (score of 2) according to time in the cutaneous distributions
of the radial, median, ulnar, and musculocutaneous nerves. *P < 0.05
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vascular puncture occurred in a total of 5 cases, 1 in
group N and 4 in group U. Signs of toxicity related to
local anesthetics were not noted in any of the patients
in either group.
Discussion
In the present study, brachial plexus block was
performed on uremic and nonuremic patients at a
volume that was calculated according to a formula
that takes height as a criterion (8), using ropivacaine
at a concentration of 0.5% with an axillary approach
through the multiple injection method. At the end of
the study, in the nerves examined in both groups, no
statistically significant difference between the groups
was found in terms of sensory and motor block
quality in all of the periods of time. The duration of
sensory and motor block in the uremic patients was
not significantly different from that of the nonuremic
patients. Signs of toxicity related to local anesthetics
were not noted in any of the patients in either group.
No significant differences were found between the 2
groups hemodynamically.
It is reported that acidosis and hyperkalemia
present in chronic renal failure increases the local
anesthetic-related cardiotoxicity in the case of a
possible intravascular injection (4). The use of longacting local anesthetics is recommended for uremic
patients (10). In studies that compare the acute
toxicity of ropivacaine to bupivacaine, it is reported
that ropivacaine is at least 25% less toxic than
bupivacaine and that the threshold value of central
nervous system toxicity for ropivacaine is twice that
of bupivacaine (11,12). In this study, we preferred to
use ropivacaine for high-risk uremic patients, as the
cardiotoxicity risk is lower in the case of a possible
intravascular injection.
Patients with end-stage renal disease may present
several clinical characteristics that may predict
differences in the systemic uptake and distribution of
local anesthetics when compared with patients with
normal renal function. Such characteristics include a
hyperdynamic circulatory status, alterations in plasma
protein concentrations, and acidemia (5,6,13-15).
The duration of brachial plexus block with lidocaine,
mepivacaine, and bupivacaine has been reported
to be shorter in uremic patients than in nonuremic
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patients (10,16). This is possibly because of the fast
absorption of the local anesthetic from the region of
the brachial plexus into the circulation. However, no
differences were reported in some other studies with
respect to patient-reported duration of the brachial
plexus block with lidocaine or bupivacaine (17). The
plasma concentrations of bupivacaine after brachial
plexus block were larger (16) than, or similar (17) to,
those in nonuremic patients.
Ropivacaine, used as the local anesthetic in this
study, was previously used by Pere et al. (7) for brachial
plexus block with an axillary approach in uremic and
nonuremic patient groups. However, different from
the current study, they administered 50 mL of 0.5%
ropivacaine using the single injection method for each
patient. They concluded that uremic and nonuremic
patients exhibited a similar quality of axillary
brachial plexus block with ropivacaine. However, the
pharmacokinetic data of their study showed that in
uremic patients, faster absorption into the circulation
and increased binding to α1-acid glycoprotein,
reducing liver extraction, led to significantly larger
plasma concentrations of ropivacaine. Again in the
same study, a successful sensory block was obtained
in the uremic patients in the innervation areas of the
musculocutaneous, radial, median, and ulnar nerves
at rates of 90%, 83%, 93%, and 100%, respectively,
and in the nonuremic patients in the innervation
areas of the musculocutaneous, radial, median, and
ulnar nerves at rates of 89%, 96%, 100%, and 100%,
respectively. When considered in terms of motor
block, excluding forearm flexion, no significant
differences were observed between the 2 groups. It
was observed that forearm flexion fully disappeared
at a rate of 72% in the uremic patients and 82% in the
nonuremic patients.
Additionally, when the qualities of sensory and
motor block in the uremic and nonuremic patients
in the present study on whom axillary block was
performed were compared, no significant differences
were found between the 2 groups. In the uremic group,
complete sensory and motor block was observed at a
rate of 95% in the ulnar nerve innervation area and
100% in the other 3 nerves; in the nonuremic group,
complete sensory and motor block was observed
at a rate of 95% in the musculocutaneous nerve
innervation area and 100% in the other 3 nerves. Even
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though a higher volume of ropivacaine (50 mL) was
used in the study mentioned above (7) than in this
study (30-35 mL), the block success rates obtained in
this study were higher.
As reported in the literature, the type of surgery
was different in the uremic patients (arteriovenous
fistula on the forearm) and the nonuremic patients
(various operations of the forearm, wrist, and hand);
therefore, the onset of pain cannot be considered
a reliable measure of the duration of the block (7).
Moreover, when the block durations in the uremic
and nonuremic groups were examined, it was found
that the duration of sensory and motor block in the
uremic group was not significantly different from
that in the nonuremic group.
In brachial plexus block performed with an
axillary approach where paresthesia-seeking, nervestimulating, perivascular, transarterial, or ultrasoundguided techniques are used, successful blockade
of individual nerves varies from 60% to nearly
100%, depending on the technique (18). Though
expensive, use of ultrasound to guide injections is
growing (19). In the studies performed, it has been
concluded that ultrasound guidance has resulted
in either similar (20) or marginally higher success
rates when compared with nerve-stimulating (21) or
perivascular techniques (22). In a study conducted by
Koscielniak-Nielsen (23), it is stated that ultrasound
guidance shortens the block performance time,
reduces the number of needle insertions, and

shortens the block onset time, and, furthermore, that
blocks may be performed using lower local anesthetic
doses. Additionally, in the same study, it was pointed
out that block effectiveness is not significantly better
than using a nerve stimulator, but ultrasound is
probably more effective than other methods on nerve
localization.
According to the research reported in the literature,
blocks performed using 2-, 3-, or 4-injection methods
result in higher success rates, shorter latency, and
higher complete block rates when compared to the
single injection method (24-28). Fanelli et al. (29)
reported a success rate of 94% using local anesthetics
(less than 30 mL) and the multiple injection method
in their retrospective study. The effects of the multiple
injection method on uremic patients are not stated
in the above studies. However, based on the findings
of the present study, it is thought that even though
a lower volume was administered, the block success
rate increased as a result of the multiple injection
method used.
Axillary brachial plexus block using the multiple
injection method with ropivacaine in uremic and
nonuremic patients provided a similarly good quality
of block and lack of systemic toxicity. For this reason,
we suggest that, in uremic patients, the performance
of an axillary block through multiple injections for
fistula operations may increase the block success rate
when compared to the single injection method.
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